Delivery Order SPE2DB22D2103-SPE2DB25FR9EU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,402.26 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (100 count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.60 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,615.32 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on December 29, 2025, with an ultimate completion date of December 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.28 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100-count packaging). This firm fixed-price, non-competitive delivery order was awarded on December 5, 2025, with an ultimate completion date of December 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,108.46 to AmerSourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-300-40 mg tablets (100 count) on January 27, 2026, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerSourceBergen's parent...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.63 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine 90-count tablets, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement issued on August 4, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.18 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract utilizes firm fixed-price pricing and is not designated as a set-aside award, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,538.79 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-300-40mg tablets in a quantity of 100 units. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.04 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 milligram tablets in a quantity of 100 units. This firm fixed-price delivery order, awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, was not set aside for any specific business type and represents a competitive award. The place of performance is listed as Conshohocken, Pennsylvania, which serves as...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9EUDelivery Order
The Defense Logistics Agency awarded a $4,242.27 delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (100 count). This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, holds a comprehensive global pharmaceutical support contract enabling the supply of medications and medical supplies to military healthcare programs worldwide. The company competitively demonstrates capability to meet federal procurement requirements across a broad spectrum of pharmaceutical products, ranging from generic to brand-name medications, vaccines, and specialized medical supplies. This delivery order for the pain management pharmaceutical reflects the company's role as a critical vendor supporting Defense Health Agency and other government healthcare systems through the DLA's flexible and extensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 5/1/25 |